CD44 and neoplasm: Thus, CSCs have been identified in a variety of solid malignancies with the identification of CSCs in these tumours being based on cell surface markers such as CD24, CD44, CD133 and Sca-1 (Singh et al, 1990; Al-Hajj et al, 2003; Xin et al, 2005).